Jimmy Lee, MBBS, MMed, MCI

JCP
Clozapine Delay and Schizophrenia Outcomes
Original Research

August 23, 2023

Clozapine is the drug of choice for treatment-resistant schizophrenia, but delays in initiation and underutilization may hinder its effectiveness. This study examined whether delay in clozapine initiation led to...
Claire Law, Yuen Mei See, Jie Yin Yee, et al
JCP
Clozapine Use in Singapore and Hong Kong
Original Research

May 18, 2022

This survey investigated clinicians’ use of clozapine for schizophrenia, beliefs about its effectiveness, and concerns regarding this medication.
Shushan Zheng, Jimmy Lee, Sherry Kit Wa Chan
JCP
Article

February 22, 2017

What's the best way to switch to clozapine in patients with treatment-resistant schizophrenia? Do you worry that efficacy and tolerability will be compromised? This pilot, double-blind RCT addresses your...
Hiroyoshi Takeuchi, Jimmy Lee, Gagan Fervaha, et al
JCP
Article

May 25, 2016

Clozapine is the most effective antipsychotic used in the treatment of refractory schizophrenia. But how do factors like smoking and caffeine intake affect plasma clozapine levels? The authors of...
Jimmy Lee, Robert Bies, Hiroyoshi Takeuchi, et al
JCP
Letter to the Editor

April 27, 2016

Jimmy Lee, Gary Remington
JCP
Original Research

December 23, 2015

Jimmy Lee, Robert Bies, Amaal Bhaloo, et al
JCP
Original Research

July 22, 2015

Gagan Fervaha, Hiroyoshi Takeuchi, Ofer Agid, et al
JCP
Original Research

October 18, 2011

Kang Sim, Wai-Yen Chan, Hui-Qi Low, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe